Dengue Vaccines Market
- 2026 年市場規模
- USD 434.8 Mn
- 2033 年預估規模
- USD 1,689.7 Mn
- 年複合成長率 CAGR
- 14.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Dengue Vaccines Market, By End User (Hospitals, Government Institutes, NGOs), By Geography ( North America, Latin America, Middle East, Africa and Asia Pacific)
報告摘要
Dengue fever is a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely to affect individual’s tropical and subtropical countries. Increasing prevalence of dengue is expected to propel growth of the global dengue vaccine market over the forecast period.
Key features of the study
• This report provides in-depth analysis of the global Dengue Vaccine and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global Dengue Vaccine based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Dengue Vaccine report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
• By End User
o Hospitals
o Government Institutes
o NGOs
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Sanofi
o Takeda Pharmaceutical Company Limited
o GlaxoSmithKline
o Merck & Co
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Key Developments
o Product Approval
o Regulatory Scenario
4. Global Dengue Vaccine Market, By End User 2026– 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Hospitals
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Government Institutes
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o NGOs
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Dengue Vaccine Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021-2033
o North America
Market Size and Forecast, By End User, 2026-2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By End User, 2026-2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Asia Pacific
Market Size and Forecast, By End User, 2026-2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
Market Size and Forecast, By End User, 2026-2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By End User, 2026-2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
o Rest of World
Market Size and Forecast, By End User, 2026-2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)
6. Competitive Landscape
o Company Profiles
Sanofi
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Takeda Pharmaceutical Company Limited
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
GlaxoSmithKline
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Merck & Co.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
7. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們